Medtronic plc (Dublin, Ireland) acquired the assets of Aptus Endosystems Inc (Sunnyvale, CA) for approximately $110 million. Aptus is a privately held medical device company focused on developing advanced technology for endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR). Medtronic will report the Aptus business as part of its Aortic and Peripheral Vascular division within the Cardiac and Vascular Group. Additional terms of the acquisition were not disclosed.
Market Pulse transactions shown herein are provided as a matter of public record. These transactions have been compiled from press releases, corporate announcements and other public sources to provide an overview of acquisition and merger activities within the healthcare and life sciences sectors.